A robust peripheral immune response and the anti-inflammatory cytokine interleukin-10 (IL-10) are critical for maximal facial motoneuron (FMN) survival after peripheral nerve injury [1,2]. This evidence concerns the gene IL10 and peripheral nerve injury.